Adjuvant Paclitaxel and Trastuzumab for Node-Negative HER2-Positive Breast Cancer

Clinical Trial ID NCT00542451

PubWeight™ 9.62^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00542451

Top papers